Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia (PROBAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04155242
Recruitment Status : Not yet recruiting
First Posted : November 7, 2019
Last Update Posted : November 15, 2019
Sponsor:
Collaborator:
University of Nottingham
Information provided by (Responsible Party):
Massimiliano di Pietro, MD, University of Cambridge

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 1, 2024
Estimated Study Completion Date : December 1, 2024